Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Crohn Disease × Infliximab × Clear all

Phase

Phase 4 2 Phase 3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Vasculitis 1 Urogenital Neoplasms 1 Syndrome 1 Stroke 1 Stevens-Johnson Syndrome 1 Pemphigoid, Benign Mucous Membrane 1 Melanoma 1 Inflammatory Bowel Diseases 1 Hematologic Neoplasms 1 Granulomatous Disease, Chronic 1 Cytokine Release Syndrome 1 Crohn Disease 1 Colitis 1 Carcinoma, Non-Small-Cell Lung 1 Aneurysm 1

Interventions

Infliximab 1 Dexamethasone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00325078 2015-12-29

Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease

National Institutes of Health Clinical Center (CC)

Phase 1/2 Terminated

40 enrolled 11 charts

Crohn Disease, Granulomatous Disease, Chronic, Inflammatory Bowel Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡